A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus

NCT01582451 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

466

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY2605541
DRUG: Insulin glargine

Sponsor

Eli Lilly and Company